在阿尔茨海默氏病进展中的神经生理学轨迹
Kiwamu Kudo1,2, Kamalini G Ranasinghe3, Hirofumi Morise1,2
1Biomagnetic Imaging Laboratory, Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, United States.
eLife
|March 28, 2024
概括
神经同步变化,特别是α和β频段的减少,在阿尔茨海默病 (AD) 进展的早期出现,先于神经退行和认知衰退. 这些变化突显了阿尔茨海默氏症早期的功能性大脑缺陷.
科学领域:
- 神经科学是一个神经科学.
- 生物医学工程 生物医学工程
背景情况:
- 阿尔茨海默病 (AD) 涉及粉样β和陶蛋白的积累,导致突触功能障碍,神经退行和认知能力下降.
- 改变的神经振荡是阿尔茨海默病的一个已知的特征,但它们的进展和与疾病严重程度的关系仍然不清楚.
研究的目的:
- 为了研究阿尔茨海默病不同阶段异常神经同步的进展.
- 确定神经同步轨迹与AD中神经退行和认知衰退之间的关系.
主要方法:
- 利用基于事件的测序模型 (EBM) 来分析静止状态磁脑图 (MEG) 数据.
- 跨AD阶段的远程和局部神经同步的估计轨迹.
主要成果:
- 在AD阶段观察到神经同步的渐进变化:delta-theta波段的增加和alpha和beta波段的减少.
- 发现α和β频段同步的下降会在神经退行和认知衰退之前发生.
- 远程同步变化比局部同步变化更为明显.
结论:
- 神经元同步的频率特异性异常是阿尔茨海默病病理生理学的早期指标.
- 改变的神经同步,特别是远程连接,在阿尔茨海默病的整个过程中逐渐演变,反映了功能神经元缺陷.
相关概念视频
Alzheimer's Disease: Overview
469
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
469
Alzheimer's Disease: Treatment
184
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
184
Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Dementia
113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
113


